4 results
To assess the immunomodulatory effects of erythromycin and clindamycin in healthy volunteers.
To evaluate the efficacy and safety of BIBF 1120 in HCC patients without prior systemic treatment as compared to Sorafenib.
Primary Objective: -To test the feasibility of MRI and CT fusion with 3D rotational venogram / fluoroscopy for left ventricular lead positioning in CRT.Secondary Objectives: -Visualize the location and distance to LV lead position of MRI determined…
The revised aims of the SORCE trial are:1. Does up to three years of treatment with sorafenib increase DFS compared with placebo: a comparison of Arm C vs Arm A2. If the answer to question (i) is yes, does one year of sorafenib (Arm B) increase DFS…